Reported Q: Q2 2026 Rev YoY: -26.5% EPS YoY: -217.0% Move: +3.77%
Aehr Test Systems
AEHR
$27.39 3.77%
Exchange NASDAQ Sector Technology Industry Semiconductors
Q2 2026
Published: Jan 8, 2026

Company Status Snapshot

Fast view of the latest quarter outcome for AEHR

Reported

Report Date

Jan 8, 2026

Quarter Q2 2026

Revenue

9.88M

YoY: -26.5%

EPS

-0.11

YoY: -217.0%

Market Move

+3.77%

Previous quarter: Q1 2026

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $9.88M down 26.5% year-over-year
  • EPS of $-0.11 decreased by 217% from previous year
  • Gross margin of 25.7%
  • Net income of -3.23M
  • "Based on customer forecasts recently provided to Aehr, we believe our bookings in the second half of this fiscal year will be between $60 million and $80 million, which would set the stage for a very strong fiscal '27 that begins on May 30." - Gayn Erickson
AEHR
Company AEHR

Executive Summary

Aehr Test Systems delivered a softer-than-anticipated Q2 FY2026 as revenue declined 27% year-over-year to $9.884 million, driven by weaker WaferPak shipments and a lean quarter for the WaferPak-based business, though demand was stronger for Sonoma high-power packaged-part burn-in systems. Management signaling and a strengthening multi-end-market cadence supported a reinstatement of guidance for the second half of fiscal 2026, with projected revenue of $25โ€“$30 million and bookings running well above quarterly revenue (midpoint guidance around $70 million, with $60โ€“$80 million in the second half expected by management). In the near term, Aehr dosed more follower demand into AI processors, silicon photonics, memory (including High Bandwidth Flash), GaN, and HDDs, while maintaining a sharpened focus on reliability solutions for AI and data-center infrastructure. The company closed the Incal facility consolidation, expanded automation in Sonoma, and advanced wafer-level burn-in benchmarks with leading AI processor suppliers, underscoring the strategic pivot toward higher-volume, higher-value burn-in solutions. The balance sheet remains healthy with roughly $31 million in cash and an ATM facility that provided $10 million gross proceeds in the quarter, underscoring managementโ€™s intent to support R&D and capacity expansion while retaining optionality. Looking ahead, Aehrโ€™s path to meaningful revenue expansion hinges on AI wafer-level burn-in adoption, capacity expansions for Sonoma and FOX platforms, and the pace of multi-end-market deployments (AI, silicon photonics, memory). Investors should weigh the near-term margin compression and operating losses against a multi-year AI-driven addressable market opportunity that Aehr appears uniquely positioned to capture.

Key Performance Indicators

Revenue
Decreasing
9.88M
QoQ: -9.89% | YoY: -26.53%
Gross Profit
Decreasing
2.55M
25.75% margin
QoQ: -31.57% | YoY: -52.87%
Operating Income
Decreasing
-4.87M
QoQ: -26.51% | YoY: -221.68%
Net Income
Decreasing
-3.23M
QoQ: -54.99% | YoY: -214.20%
EPS
Decreasing
-0.11
QoQ: -58.05% | YoY: -217.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 9.88 -0.11 -26.5% View
Q1 2026 10.97 -0.07 -16.4% View
Q4 2025 14.09 -0.10 -15.1% View
Q3 2025 18.31 -0.02 +142.1% View
Q2 2025 13.45 -0.03 -37.2% View